A detailed history of Harbor Capital Advisors, Inc. transactions in Kiniksa Pharmaceuticals, Ltd. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 97,543 shares of KNSA stock, worth $2.1 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
97,543
Holding current value
$2.1 Million
% of portfolio
0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$18.0 - $27.55 $1.76 Million - $2.69 Million
97,543 New
97,543 $2.44 Million
Q1 2024

May 13, 2024

BUY
$17.63 - $21.74 $231,693 - $285,707
13,142 New
13,142 $259,000

Others Institutions Holding KNSA

About Kiniksa Pharmaceuticals, Ltd.


  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $740M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.